Casma Therapeutics brings in another $50 million to target muscular dystrophy. (STAT)

More reads

• Casma Therapeutics brings in another $50 million to target muscular dystrophy. (STAT) 
• Novartis and Roche are fined $528 million for anti-competitive practices in France. (STAT)
• Opinion: ‘Hell has frozen over’: The pharmaceutical industry stands in for an impaired FDA. (STAT) 
• Korro Bio raises $90 million to fix mutations that cause diseases. (STAT)